APA

Durães A. R., de Souza Roriz P., de Almeida Nunes B., Albuquerque F. P. E., de Bulhões F. V., de Souza Fernandes A. M. & Aras R. (20170501). Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study. : Drugs in R&D.

Chicago

Durães André Rodrigues, de Souza Roriz Pollianna, de Almeida Nunes Bianca, Albuquerque Felipe Pinho E, de Bulhões Fábio Vieira, de Souza Fernandes Andre Mauricio and Aras Roque. 20170501. Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study. : Drugs in R&D.

Harvard

Durães A. R., de Souza Roriz P., de Almeida Nunes B., Albuquerque F. P. E., de Bulhões F. V., de Souza Fernandes A. M. and Aras R. (20170501). Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study. : Drugs in R&D.

MLA

Durães André Rodrigues, de Souza Roriz Pollianna, de Almeida Nunes Bianca, Albuquerque Felipe Pinho E, de Bulhões Fábio Vieira, de Souza Fernandes Andre Mauricio and Aras Roque. Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study. : Drugs in R&D. 20170501.